Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3764130011 | Dolasetron mesilate 20 mg powder for solution for injection ampoule | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3764131010 | Dolasetron mesylate 20 mg powder for solution for injection ampule | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3764132015 | Product containing precisely dolasetron mesilate 20 milligram/1 ampule powder for conventional release solution for injection (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
1200267015 | Dolasetron mesylate monohydr 12.5mg/amp injection (product) | en | Fully specified name | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
1213327014 | Dolasetron mesylate monohydr 12.5mg/amp injection | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
1213327014 | Dolasetron mesylate monohydr 12.5mg/amp injection | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
1458440018 | Dolasetron mesylate monohydrate 12.5mg powder for injection solution ampule (product) | en | Fully specified name | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
1458440018 | Dolasetron mesylate monohydrate 12.5mg powder for injection solution ampule (product) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
1475841013 | Dolasetron mesylate monohydrate 12.5mg powder for injection solution ampoule | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
1475841013 | Dolasetron mesylate monohydrate 12.5mg powder for injection solution ampoule | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
1476797014 | Dolasetron mesylate monohydrate 12.5mg powder for injection solution ampule | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
1476797014 | Dolasetron mesylate monohydrate 12.5mg powder for injection solution ampule | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3764130011 | Dolasetron mesilate 20 mg powder for solution for injection ampoule | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3764131010 | Dolasetron mesylate 20 mg powder for solution for injection ampule | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3764132015 | Product containing precisely dolasetron mesilate 20 milligram/1 ampule powder for conventional release solution for injection (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely dolasetron mesilate 20 milligram/1 ampule powder for conventional release solution for injection (clinical drug) | Is a | Product containing dolasetron (medicinal product) | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely dolasetron mesilate 20 milligram/1 ampule powder for conventional release solution for injection (clinical drug) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Dolasetron (substance) | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely dolasetron mesilate 20 milligram/1 ampule powder for conventional release solution for injection (clinical drug) | Has manufactured dose form | Injection (product) | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely dolasetron mesilate 20 milligram/1 ampule powder for conventional release solution for injection (clinical drug) | Is a | Dolasetron-containing product in parenteral dose form | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely dolasetron mesilate 20 milligram/1 ampule powder for conventional release solution for injection (clinical drug) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Dolasetron mesylate | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely dolasetron mesilate 20 milligram/1 ampule powder for conventional release solution for injection (clinical drug) | Has manufactured dose form | Injection solution (product) | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely dolasetron mesilate 20 milligram/1 ampule powder for conventional release solution for injection (clinical drug) | Has manufactured dose form | Powder for solution for injection | true | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely dolasetron mesilate 20 milligram/1 ampule powder for conventional release solution for injection (clinical drug) | Is a | TEMPORARY parent for CDs that are not updated | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely dolasetron mesilate 20 milligram/1 ampule powder for conventional release solution for injection (clinical drug) | Has presentation strength denominator value | un | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
Product containing precisely dolasetron mesilate 20 milligram/1 ampule powder for conventional release solution for injection (clinical drug) | Is a | Dolasetron only product in parenteral dose form | true | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely dolasetron mesilate 20 milligram/1 ampule powder for conventional release solution for injection (clinical drug) | Has presentation strength denominator unit (attribute) | Ampule | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
Product containing precisely dolasetron mesilate 20 milligram/1 ampule powder for conventional release solution for injection (clinical drug) | Has presentation strength numerator value | 20 | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
Product containing precisely dolasetron mesilate 20 milligram/1 ampule powder for conventional release solution for injection (clinical drug) | Has precise active ingredient | Dolasetron mesylate | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
Product containing precisely dolasetron mesilate 20 milligram/1 ampule powder for conventional release solution for injection (clinical drug) | Has basis of strength substance (attribute) | Dolasetron mesylate | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
Product containing precisely dolasetron mesilate 20 milligram/1 ampule powder for conventional release solution for injection (clinical drug) | Has presentation strength numerator unit (attribute) | mg | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
Product containing precisely dolasetron mesilate 20 milligram/1 ampule powder for conventional release solution for injection (clinical drug) | Has unit of presentation | Ampule | true | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely dolasetron mesilate 20 milligram/1 ampule powder for conventional release solution for injection (clinical drug) | Count of base of active ingredient | un | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely dolasetron mesilate 20 milligram/1 ampule powder for conventional release solution for injection (clinical drug) | Plays role | Antiemetic therapeutic role | false | Inferred relationship | Existential restriction modifier (core metadata concept) |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets